A global increase in H3K27 trimethylation, due to EZH2 Y641 mutation, represses genes involved in proliferation checkpoints and associated with B-cell differentiation, thus providing a possible explanation for the oncogenic role of mutant EZH2 in DLBCL [41, 46]. The gene discussed is EZH2; the disease is diffuse large B-cell lymphoma.